Dr Katherine Neville
BMed, FRANZCR, MClinEpid
For patients/carers
For doctors
BMed, FRANZCR, MClinEpid
Biography
Clinical interests in breast, skin, and lung cancers, palliative radiation therapy, and haematology
Dr Katherine Neville is an Australian trained Radiation Oncologist. She completed her undergraduate degree at the University of Newcastle in 2005 and worked throughout Hunter New England Area Health Service as a junior doctor before commencing specialty training in Radiation Oncology in 2009. Dr Neville completed her specialist training at the Calvary Mater Hospital, Royal North Shore Hospital, and Liverpool Hospital before being becoming a Fellow of the Royal Australian and New Zealand College of Radiologists (Faculty of Radiation Oncology) in 2016. She has received training in the management of all tumour types, however Dr Neville has clinical interests in the treatment of breast cancer, lung cancer, benign conditions, haematology, and palliative radiation therapy.
As well as her clinical interests, Dr Neville has been involved in research projects about mantle cell lymphoma, non small cell lung cancer, and breast cancer. She has completed her Masters of Clinical Epidemiology through the University of Newcastle.
Dr Neville consults at the Multi-disciplinary Dupuytren’s clinic in Newcastle and is co-investigator on the DEPART clinical trial.
More information
- Dupuytrens disease
- Australian & New Zealand College of Radiologists
- TROG (Trans Tasman Radiation Oncology Group)
- ESTRO (European Society for Radiotherapy & Oncology)
- ANZPROG (RANZCR Australian and New Zealand Palliative Radiation Oncology Group)
- Adoption of hypofractionated radiation therapy for early breast cancer in private practice: the GenesisCare experience 2014–2016. Journal of Medical Imaging and Radiation Oncology (JMIRO), 2020
- Involved-field radiotherapy for patients with mantle cell lymphoma. Journal of Medical Imaging and Radiation Oncology (JMIRO), 2015
This GenesisCare practitioner is a shareholder of GenesisCare Australia Holdings Pty Ltd and therefore has a pecuniary interest in GenesisCare as defined by Section 19 of the Private Health Facilities Regulation 2017 (NSW).